Balanced news tone
News Sentiment
BSXC sentiment intelligence
Boston Scientific Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
70/100 classification confidence.
directly relevant articles
high-authority source matches
-1.8% over one week, -3.1% over four weeks, trend inactive, and below fair value.
Truist Adjusts Price Target on Boston Scientific to $62 From $64, Maintains Buy Rating
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Truist Adjusts Price Target on Boston Scientific to $62 From $64, Maintains Buy Rating
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 16 Jul 2026 13:19
- Source
- marketscreener.com
Mizuho Adjusts Price Target on Boston Scientific to $70 From $90, Maintains Outperform Rating
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 15 Jul 2026 15:27
- Source
- marketscreener.com
Boston Scientific Corporation(NYSE:BSX) dropped from Russell 1000 Growth-Defensive Index
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 21:35
- Source
- marketscreener.com
Analyst recommendations: Adobe, Boston Scientific, Casey's General Stores, Kla Corporation, Zillow Group…
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 12 Jun 2026 07:00
- Source
- marketscreener.com
Boston Scientific Stock Decline 2026: Guidance Cuts and Analyst Outlook - News and Statistics
- Tone
- Negative 18/100
- Event
- Guidance
- Published
- 12 Jun 2026 07:00
- Source
- IndexBox
Spotting Winners: Boston Scientific (NYSE:BSX) And Medical Devices & Supplies - Diversified Stocks In Q1
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- Market source
Bernstein Adjusts Boston Scientific Price Target to $76 From $97, Maintains Outperform Rating
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 28 May 2026 07:00
- Source
- marketscreener.com
Boston Scientific reports steady Q1 2026 performance yet tempers FY26 outlook
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 23 Apr 2026 07:00
- Source
- Medical Device Network
Boston Scientific Corporation Provides Earnings Guidance for the Second Quarter and Full Year 2026
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 22 Apr 2026 07:00
- Source
- marketscreener.com
Boston Scientific 1Q Net Grows Sharply, Company Cuts 2026 Adjusted EPS View
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 22 Apr 2026 07:00
- Source
- marketscreener.com
Boston Scientific cuts annual forecast, shares rise on reset
- Tone
- Negative 34/100
- Event
- Guidance
- Published
- 22 Apr 2026 07:00
- Source
- marketscreener.com
Boston Scientific Q1 Adjusted Earnings, Net Sales Increase; 2026 Guidance Lowered
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 22 Apr 2026 07:00
- Source
- marketscreener.com
Leerink Partners Adjusts Price Target on Boston Scientific to $89 From $95, Maintains Outperform Rating
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 20 Mar 2026 07:00
- Source
- marketscreener.com
Securities Fraud Investigation Into Boston Scientific Corporation (BSX) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
- Tone
- Negative 34/100
- Event
- Regulatory and legal
- Published
- 09 Feb 2026 08:00
- Source
- marketscreener.com
Boston Scientific’s shares tumble 18% despite strong FY25 growth
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 05 Feb 2026 08:00
- Source
- Medical Device Network
Boston Scientific Plunges on Disappointing 1Q Outlook Despite 4Q Earnings Beat
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 04 Feb 2026 08:00
- Source
- marketscreener.com
JPM26: Boston Scientific acquires Penumbra in $14.5bn deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 15 Jan 2026 08:00
- Source
- Medical Device Network
Boston Scientific Corp (MIL:1BSX) Stock Price, Trades & News
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Nov 2023 12:26
- Source
- GuruFocus